Microbubble treatment of liver cancer

Share This Post

Hepatitis C is primarily to blame for liver cancer, one of the deadliest cancers. In addition, complications of fatty liver disease are also a cause of liver cancer. At present, researchers are trying to treat liver cancer by improving microbubbles. Microbubbles, including the sturdy outer shell and small gas bubbles inside the gas, insert glass radiation beads into the liver, and then inject the microbubbles into the blood. It is usually used in combination with radiation therapy for the treatment of advanced liver cancer.

Dr. John Eisenbrey, a radiology researcher at Thomas Jefferson University, said, “focusing the ultrasound beam on the liver tumor, the bubbles participate in the blood circulation in the body. The ultrasound only focuses on the tumor itself, and it does not affect the surrounding healthy tissue, and only generates bubbles inside the tumor. The blood supply through the catheter is only deposited in the tumor. When the bubbles burst, it will enhance the radiation effect. This therapy is to destroy the blood supply and starve the tumor, and then the tumor begins to shrink over time. It is still in The early stages of clinical trials have shown good results.

At present, researchers are using commercial bubbles outside the label, and at the same time working with chemists and engineers to put chemotherapy drugs, oxygen and other compositions into microbubbles to circulate in the blood to achieve the purpose of shrinking tumors and extending the life of patients.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Efficacy of CAR T Cell Therapy in B-Cell lymphoma Richter Transformation
CAR T-Cell therapy

Efficacy of CAR T Cell Therapy in B-Cell lymphoma Richter Transformation

CAR T cell therapy has shown promising efficacy in treating B-cell lymphoma Richter Transformation, a rare and aggressive disease. This advanced therapy involves genetically modifying a patient’s T cells to target and destroy cancerous B cells. Clinical trials indicate significant response rates, with some patients achieving complete remission. Despite challenges like potential severe side effects, CAR T cell therapy represents a groundbreaking approach, offering hope for improved outcomes in this difficult-to-treat condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy